CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.
Authors
Caroline P. Babin
Elyse M. Cornett
+8Â more
Alyssa G. Derouen
Amber N Edinoff
Adam M. Kaye
Alan David Kaye
Salim C. Lutfallah
Kevin S Murnane
Catherine A. Nix
Amira S. Odisho
Publication date
22 August 2022
Publisher
Scholarly Commons
Abstract
As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-
Similar works
Full text
Available Versions
Pacific McGeorge School of Law
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:scholarlycommons.pacific.e...
Last time updated on 24/02/2023